⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Official Title: Post-marketing Surveillance of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV)-16/18 Vaccine, Cervarix When Administered According to the Approved Prescribing Information in Korea

Study ID: NCT03671369

Study Description

Brief Summary: The purpose of this post-marketing surveillance (PMS) study is to collect safety information on the use of Cervarix upon the expanded indication to anal cancer to both women and men (at least 600 Korean women and men) within 30 days after each vaccination dose, when administered according to the approved prescribing information (PI) in Korea in a real health care setting over a period of 4 years.

Detailed Description:

Eligibility

Minimum Age: 9 Years

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

GSK Investigational Site, Busan, , Korea, Republic of

GSK Investigational Site, Chungcheongnam-do, , Korea, Republic of

GSK Investigational Site, Daegu, , Korea, Republic of

GSK Investigational Site, Gongju-si, Chungcheongnam-do, , Korea, Republic of

GSK Investigational Site, Gwangju, , Korea, Republic of

GSK Investigational Site, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Gyeongsangbuk-do, , Korea, Republic of

GSK Investigational Site, Gyeongsangbuk-do, , Korea, Republic of

GSK Investigational Site, Incheon, , Korea, Republic of

GSK Investigational Site, Jeollabuk-do, , Korea, Republic of

GSK Investigational Site, Jeollabuk-do, , Korea, Republic of

GSK Investigational Site, Jeonju-si, Jeollabuk-do, , Korea, Republic of

GSK Investigational Site, Jeonju-si,Jeollabuk-do, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Suwon-si, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Suwon-si, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Yangju-si, Gyeonggi-do, , Korea, Republic of

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: